106P Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies

Yanggang Yuan(Jiangsu Province Hospital), Kaiyang Ding(Anhui Provincial Hospital), Mingyu Sun(Shanghai University of Traditional Chinese Medicine), Mingming Zhao(Peking University), Deyan Wu(Sun Yat-sen University), Xiao-Fei Dong(Union Hospital), Zijian Zhang(Duke University), Li Liu(Hangzhou Hospital of Traditional Chinese Medicine), Zhou Wang(XinHua Hospital), Hui Wang(Henan Medical University), John Wang(Hunan University of Traditional Chinese Medicine), Yueyin Pan(University of Science and Technology of China), Yujie Hu(Chinese PLA General Hospital), Yizhou Deng(Sun Yat-sen University), Dandan Huang(Tianjin Medical University Cancer Institute and Hospital), Ning Yang(First Affiliated Hospital of Hebei Medical University), Zengqing Guo(Fujian Provincial Cancer Hospital)
Annals of Oncology
November 1, 2023
Cited by 11


Related Papers